Top Story

FDA approves new trial of LAA closure device

July 1, 2015

The FDA has approved an investigational device exemption to initiate the randomized, controlled AMAZE trial to evaluate use of the Lariat device for left atrial appendage closure as an adjunctive treatment to pulmonary vein isolation in patients with atrial fibrillation, according to a press release from SentreHEART.

Researchers for the AMAZE trial will randomly assign patients with persistent or long-term persistent AF to receive the Lariat device plus pulmonary vein isolation ablation or pulmonary vein isolation ablation alone. The primary outcome will be incidence of recurrent AF, according to the release.

Dariush Mozaffarian In the Journals

Sugary drinks tied to 184,000 deaths annually worldwide

July 1, 2015
Sugar-sweetened beverages contribute to 184,000 deaths per year worldwide, primarily from diabetes and cardiovascular disease, according to research in Circulation.In…
In the Journals

RIBS IV: EES superior to DEB for DES in-stent restenosis

July 1, 2015
Everolimus-eluting stents yielded superior long-term outcomes compared with drug-eluting balloons for the treatment of patients with drug-eluting stent in-stent…
Perspective

IOM report calls for national cardiac arrest registry, more CPR training

July 1, 2015
The Institute of Medicine released a report recommending several actions to improve survival rates and quality of life after cardiac arrest, including establishing a…
Blog

BLOG: Health care providers need to consider options offered by patient financing programs

July 1, 2015
Most health care practices have financial policies in place that require payment by cash, check or major credit card for out-of-pocket costs. However, in today’s…
More News Headlines »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Cardiology Case Consults

The Patient with Acute Coronary Syndrome

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute coronary syndrome.
More »
morganatic-roan